Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Challiss

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
The Biochemical Journal|July 1, 1991
Is decavanadate a specific inositol 1,4,5-trisphosphate receptor antagonist?J Strupish, R J Wojcikiewicz, R A Challiss, et al.
The Journal of Biological Chemistry|August 24, 2000
Lysophosphatidic acid-induced Ca2+ mobilization requires intracellular sphingosine 1-phosphate production. Potential involvement of endogenous EDG-4 receptorsK W Young, M D Bootman, D R Channing, et al.
The Journal of Biological Chemistry|October 28, 1994
Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptorR A Wilcox, R A Challiss, J R Traynor, et al.
The Biochemical Journal|June 15, 1987
Effects of prolonged elevation of plasma adrenaline concentration in vivo on insulin-sensitivity in soleus muscle of the ratL Budohoski, R A Challiss, A Dubaniewicz, et al.
European Journal of Clinical Investigation|June 1, 1997
The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid ratsG Dimitriadis, M Parry-Billings, S Bevan, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 14, 2000
Spirophostins: conformationally restricted analogues of adenophostin AM de Kort, A D Regenbogen, A R Valentijn, et al.
Journal of the Neurological Sciences|February 1, 1988
An animal model of mitochondrial myopathy: a biochemical and physiological investigation of rats treated in vivo with the NADH-CoQ reductase inhibitor, diphenyleneiodoniumJ M Cooper, R K Petty, D J Hayes, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
The Biochemical Journal|July 1, 1991
Is decavanadate a specific inositol 1,4,5-trisphosphate receptor antagonist?J Strupish, R J Wojcikiewicz, R A Challiss, et al.
The Journal of Biological Chemistry|August 24, 2000
Lysophosphatidic acid-induced Ca2+ mobilization requires intracellular sphingosine 1-phosphate production. Potential involvement of endogenous EDG-4 receptorsK W Young, M D Bootman, D R Channing, et al.
The Journal of Biological Chemistry|October 28, 1994
Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptorR A Wilcox, R A Challiss, J R Traynor, et al.
The Biochemical Journal|June 15, 1987
Effects of prolonged elevation of plasma adrenaline concentration in vivo on insulin-sensitivity in soleus muscle of the ratL Budohoski, R A Challiss, A Dubaniewicz, et al.
European Journal of Clinical Investigation|June 1, 1997
The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid ratsG Dimitriadis, M Parry-Billings, S Bevan, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 14, 2000
Spirophostins: conformationally restricted analogues of adenophostin AM de Kort, A D Regenbogen, A R Valentijn, et al.
Journal of the Neurological Sciences|February 1, 1988
An animal model of mitochondrial myopathy: a biochemical and physiological investigation of rats treated in vivo with the NADH-CoQ reductase inhibitor, diphenyleneiodoniumJ M Cooper, R K Petty, D J Hayes, et al.
Pageof 15